Explore All 789 Divestiture Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | August 22, 2018 |
| Target | Vical - GMP Facility |
| Sector | Life Science |
| Buyer(s) | Helixmith |
| Sellers(s) | Vical |
| Deal Type | Divestiture |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1996 |
| Sector | Life Science |
| Employees | 106 |
| Revenue | 5.0B KRW (2024) |
Helixmith is a biotechnology company develops bio-pharmaceuticals for human diseases in South Korea. Helixmith was founded in 1996 and is based in Seoul, South Korea.
| Deal Context for Buyer | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science | 2 of 2 |
| Type: Divestiture | 1 of 1 |
| State: California | 1 of 1 |
| Country: United States | 1 of 1 |
| Year: 2018 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2009-11-10 |
Helixir Co.
Seoul, South Korea Helixir Co., Ltd. is a developer of nutraceuticals and pharmaceuticals from herbal medicines in the United States, Japan, the European Union, and Korea. |
Buy | - |
| Category | Company |
|---|---|
| Founded | 1987 |
| Sector | Life Science |
| Employees | 30 |
| Revenue | 2M USD (2018) |
Vical, Inc. develops biopharmaceutical products for the prevention and treatment of chronic or life-threatening infectious diseases, based on company patented DNA delivery technologies and other therapeutic approaches. Vical was founded in 1987 and is based in San Diego, California.
| Deal Context for Seller | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science | 1 of 1 |
| Type: Divestiture | 1 of 1 |
| State: California | 1 of 1 |
| Country: United States | 1 of 1 |
| Year: 2018 | 1 of 1 |
